Ingevity Corporation
General ticker "NGVT" information:
- Sector: Materials
- Industry: Chemicals
- Capitalization: $1.7B (TTM average)
Ingevity Corporation follows the US Stock Market performance with the rate: 67.5%.
Estimated limits based on current volatility of 1.1%: low 51.65$, high 52.85$
Factors to consider:
- Total employees count: 1600 as of 2024
- China accounted for 13.1% of revenue in the fiscal year ended 2024-12-31
- US accounted for 52.3% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Dependence on key customers, Cybersecurity threats, Geopolitical risks, Labor/talent shortage/retention, Environmental regulations
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [31.64$, 52.37$]
- 2025-12-31 to 2026-12-31 estimated range: [35.25$, 57.20$]
Financial Metrics affecting the NGVT estimates:
- Negative: with PPE of 11.5 at the end of fiscal year the price was very high
- Positive: 7.86 < Operating profit margin, % of 18.48
- Negative: Shareholder equity ratio, % of 9.65 <= 18.93
- Positive: 6.82 < Operating cash flow per share per price, % of 8.64
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of 4.95 <= 5.52
- Positive: -14.38 < Investing cash flow per share per price, % of -5.34
- Positive: 0 < Industry earnings per price (median), % of 2.23
- Positive: Industry inventory ratio change (median), % of -0.31 <= -0.15
Short-term NGVT quotes
Long-term NGVT plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $1,677.50MM | $1,692.10MM | $1,406.40MM |
| Operating Expenses | $1,407.90MM | $1,435.70MM | $1,146.50MM |
| Operating Income | $269.60MM | $256.40MM | $259.90MM |
| Non-Operating Income | $0.00MM | $-266.50MM | $-795.50MM |
| Interest Expense | $61.80MM | $93.30MM | $97.80MM |
| R&D Expense | $30.30MM | $31.80MM | $28.10MM |
| Income(Loss) | $269.60MM | $-10.10MM | $-535.60MM |
| Taxes | $58.00MM | $-4.70MM | $-105.30MM |
| Profit(Loss)* | $211.60MM | $-5.40MM | $-430.30MM |
| Stockholders Equity | $698.30MM | $631.40MM | $195.20MM |
| Inventory | $335.00MM | $308.80MM | $226.80MM |
| Assets | $2,736.50MM | $2,623.30MM | $2,022.60MM |
| Operating Cash Flow | $313.40MM | $205.10MM | $128.60MM |
| Capital expenditure | $142.50MM | $109.80MM | $77.60MM |
| Investing Cash Flow | $-551.90MM | $-77.30MM | $-79.50MM |
| Financing Cash Flow | $48.10MM | $-99.90MM | $-70.20MM |
| Earnings Per Share** | $5.50 | $-0.15 | $-11.85 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.